Article ID Journal Published Year Pages File Type
2478815 Drug Metabolism and Pharmacokinetics 2012 7 Pages PDF
Abstract

Summary:Glucuronidation is an important pathway in the elimination of salvianolic acid A (Sal A); however the mechanism of UDP-glucuronosyltransferases (UGTs) in this process remains to be investigated. In this study, the kinetics of Sal A glucuronidation by pooled human liver microsomes (HLMs), pooled human intestinal microsomes (HIMs) and 12 recombinant UGT isozymes were investigated. The glucuronidation of Sal A can be shown both in HLMs and HIMs with Km values of 39.84 ± 3.76 and 54.04 ± 4.36 μΜ, respectively. Among the 12 human UGTs investigated, UGT1A1 and UGT1A9 were the major isoforms that catalyzed the glucuronidation of Sal A (Km values of 29.72 ± 2.20 and 24.40 ± 2.60μΜ). UGT1A9 showed the highest affinity of Sal A glucuronidation. Furthermore, a significant correlation between Sal A glucuronidation and propofol glucuronidation (a typical UGT1A9 substrate) was observed. The chemical inhibition study showed that the IC50 for phenylbutazone inhibition of Sal A glucuronidation was 50.3 ± 4.3 and 39.4 ± 2.9 μΜ by HLMs and UGT1A9, respectively. Mefenamic acid inhibited Sal A glucuronidation in UGT1A1 and HLMs with IC50 values of > 200 and 12.4 ± 2.2 μM, respectively.

Related Topics
Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Drug Discovery